At a glance
ClinicalIndex Comparison RecordN/ACompleted· 26 enrolled
Drug / intervention
Measure plasma and dialysate level of IL-6, procalcitonin and VEGFother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Interleukin-6, Procalcitonin and Vascular Endothelial Growth Factor in Plasma and Dialysate Correlate With Peritoneal Solute Transport and Dialysis Adequacy in CAPD Patients
Bangkok Metropolitan Administration Medical College and Vajira Hospital·observational·Posted Aug 29, 2016·Updated Aug 29, 2016
In Brief
An observational study evaluating Measure plasma and dialysate level of IL-6, procalcitonin and VEGF for Chronic Kidney Disease. Completed, enrolled 26 participants across 1 site.
Detailed Summary
The aim of study was to evaluated the correlation between plasma levels, dialysate appearance rate of VEGF, inflammatory cytokines (IL- 6, procalcitonin) and PSTR, dialysis adequacy in CAPD patients.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Kidney Disease
CountriesThailand
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2012
Primary CompletionMay 2014
Study CompletionJun 2014
First PostedAug 2016
TodayJul 2026
First PostedAug 29, 2016
Enrollment StartMar 1, 2012
Primary CompletionMay 1, 2014
Study CompletionJun 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 9.8 years ago
Interventions
Measure plasma and dialysate level of IL-6, procalcitonin and VEGFother
correlation between plasma levels, dialysate appearance rate of VEGF, inflammatory cytokines (IL- 6, procalcitonin) and PSTR, dialysis adequacy in CAPD patients.